Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after ...

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the future of pharmaceutical advertising, health ...

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

He prefers Mounjaro over Ozempic, another popular GLP-1 inhibitor, due to its fewer side effects and increased effectiveness.

The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a ...

A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar ...

CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

Jim Gaffigan opened up about shedding 50 pounds on The View, sharing a moment with co-host Whoopi Goldberg as they discussed ...

A slimmer Elon Musk revealed on Wednesday that he uses Mounjaro, a weight-loss drug, after previously advocating for similar ...

Elon Musk took to X on Wednesday to revel in the Christmas spirit. He also reportedly credited Mounjaro for his weight loss.

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...